CoQ10
CoQ10

Likely modest benefit Published May 11, 2026

CoQ10 for Lower LDL: What 14 Studies Actually Show

Direct answer

CoQ10 appears to lower LDL a little. Across 14 studies with 9367 people, average LDL dropped 9.18 mg/dL; the research here does not pin down a precise range around that average, and 9.18 mg/dL is only 0.61 of the 15.0 mg/dL change people usually treat as noticeable—more of a nudge than a big shift. Taken together, the evidence looks moderately convincing but not ironclad, and the average study lasted 12 weeks.54

14 studies · 9,367 participants · typical duration 12 wk · 20 sources

CoQ10 has a reputation for statin muscle complaints, so a lot of people assume it must also be a strong cholesterol supplement. LDL does move in the right direction, but the average drop is smaller than most people expect.

That matters if your goal is a clearly better lipid panel, not just “something natural” in the cabinet. CoQ10 looks more useful as an add-on nudge than as the thing that carries your whole LDL plan.

How it works

CoQ10 works inside mitochondria—the tiny generators in your cells—where it ferries electrical charge from one step of energy production to the next like a relay runner keeping the baton moving without losing speed.2 It does not scrub LDL out of your bloodstream directly. The LDL change likely happens downstream, because better energy handling and less oxidative wear can improve how the liver and other tissues process fats, which is why trials tend to show a small shift instead of a dramatic plunge.49

What the studies show

The headline result is simple: across 14 studies and 9367 participants, CoQ10 lowered LDL by 9.18 mg/dL over a typical 12 weeks.56 Put against the 15.0 mg/dL threshold used here for a clearly noticeable change, that lands at 0.61 of that mark—real, but small.5

That size matters. A 9.18 mg/dL drop can look nice on paper, yet it stays below the change most people would count as clearly meaningful on its own. CoQ10 looks more like an add-on nudge than a standalone LDL strategy.5

The signal mostly comes from people with cardiometabolic problems—type 2 diabetes, coronary artery disease, dyslipidemia, and some statin-treated groups—not from broad samples of otherwise healthy adults.4589 That makes the result more relevant if your LDL issue sits inside a bigger metabolic picture.

Individual trials point the same way without turning CoQ10 into a blockbuster. Placebo-controlled studies in type 2 diabetes and dyslipidemia reported lipid improvements, but the populations, formulations, and background treatments varied enough that you should expect uneven results from person to person.489

Caveats worth knowing

  • ·

    Mostly studied in people with diabetes, coronary disease, dyslipidemia, or statin use

  • ·

    Average trial length was 12 weeks, so long-term durability is still unclear

  • ·

    Formulations differed across trials, including standard CoQ10, ubiquinol, and liquid products

  • ·

    Background treatment varied, especially in statin-treated groups

  • ·

    The average LDL drop stayed below the 15.0 mg/dL threshold used here for a clearly noticeable change

Watch-outs

  • Stomach upset is the most common downside

    Nausea, diarrhoea, and flatulence show up across CoQ10 trials. These were usually mild, but they are the side effects you are most likely to notice first.9161718

    Severity: low

  • Headache shows up in some users

    Some trials reported headache after starting CoQ10. If a new recurring headache starts with the supplement, stopping it is a reasonable reality check.16

    Severity: low

  • Rare serious blood-count problems were reported

    One placebo-controlled trial reported grade 3 or 4 neutropenia and leukopenia. That is rare, but it means CoQ10 is not automatically risk-free in medically complex settings.20

    Severity: high

Practical guidance

Use CoQ10 like a lab experiment, not a “feel it working” supplement. If LDL is your target, keep the rest of your routine steady and recheck your lipid panel after about 12 weeks, because that is the usual study window.5

If your LDL has not moved by then, CoQ10 has probably given you most of what it is going to give. The studies used different formulations and different background treatments, so the smartest way to judge it is by your repeat blood test, not by marketing claims or day-to-day sensations.489

People also ask

What is the best supplement to lower cholesterol?

There is no universal “best” supplement. For LDL specifically, CoQ10 lowers cholesterol a little on average—about 9.18 mg/dL in the combined trials—so it looks more like an add-on than a main driver.

What do cardiologists say about CoQ10?

Cardiologists usually treat CoQ10 as an adjunct, not a replacement for standard cholesterol care. It gets the most attention around statin-related muscle symptoms, while its LDL effect stays small on average.

How long does it take CoQ10 to lower cholesterol?

About 12 weeks is the practical checkpoint. That is the typical study length, so if your lipid panel stays unchanged after roughly 3 months, the research does not point to a big delayed LDL drop later.

Is there any downside to taking CoQ10?

Usually the downside is mild stomach upset or headache, but rare serious blood-count problems have been reported in one trial. “Natural” does not mean zero-risk.

What flushes cholesterol out of your body?

CoQ10 does not flush cholesterol out of your body like a drain cleaner. If it works for LDL, it seems to improve how cells handle energy and fats, which can nudge the number down a bit in some groups.

Is 2 eggs a day bad for high cholesterol?

These CoQ10 trials do not answer the egg question directly. What they do show is that a supplement alone usually moves LDL less than people expect, so your overall eating pattern still matters more.

Sources

Sources

  1. 1. Coenzyme Q10 and exercise training in chronic heart failure.
  2. 2. Coenzyme Q10 improves endothelial dysfunction in statin-treated type 2 diabetic patients.
  3. 3. Coenzyme Q10 supplementation decreases statin-related mild-to-moderate muscle symptoms: a randomized clinical study.
  4. 4. Effects of CoQ10 Supplementation on Lipid Profiles and Glycemic Control in Patients with Type 2 Diabetes: a randomized, double blind, placebo-controlled trial.
  5. 5. The effects of coenzyme Q10 supplementation on lipid profiles among patients with coronary artery disease: a systematic review and meta-analysis of randomized controlled trials.
  6. 6. Effectiveness of Coenzyme Q10 Supplementation for Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.
  7. 7. Effects of coenzyme Q10 intervention on diabetic kidney disease: A systematic review and meta-analysis.
  8. 8. Coenzyme q10 liquid supplementation in dyslipidemic subjects with statin-related clinical symptoms: a double-blind, randomized, placebo-controlled study.
  9. 9. Coenzyme Q10 supplementation improves adipokine profile in dyslipidemic individuals: a randomized controlled trial.
  10. 10. Comparison of nutritional supplements in improving glycolipid metabolism and endocrine function in polycystic ovary syndrome: a systematic review and network meta-analysis.
  11. 11. The effect of coenzyme Q10 intake on metabolic profiles in women candidates for in-vitro fertilization: a randomised trial.
  12. 12. Cardiorespiratory fitness and effects of ubiquinol during high-altitude acclimatization and deacclimatization: The SCARF trial.
  13. 13. The effectiveness of nutritional supplements in improving polycystic ovary syndrome in women: a systematic review and network meta-analysis.
  14. 14. Co-enzyme Q10 supplementation for the primary prevention of cardiovascular disease.
  15. 15. No Effect of Coenzyme Q10 on Cognitive Function, Psychological Symptoms, and Health-related Outcomes in Schizophrenia and Schizoaffective Disorder: Results of a Randomized, Placebo-Controlled Trial.
  16. 16. The effect of coenzyme Q10 pretreatment on ovarian reserve in women undergoing hysterectomy with bilateral salpingectomy: a randomised, double-blind, placebo-controlled trial.
  17. 17. PMID 33402403
  18. 18. High-dose ubiquinol supplementation in multiple-system atrophy: a multicentre, randomised, double-blinded, placebo-controlled phase 2 trial.
  19. 19. Efficacy of Berberine Alone and in Combination for the Treatment of Hyperlipidemia: A Systematic Review.
  20. 20. A randomized, double-blind, placebo-controlled study of oral coenzyme Q10 to relieve self-reported treatment-related fatigue in newly diagnosed patients with breast cancer.

Want personalized recommendations?

Show me what works for me